Portable self-help medical imaging device for home-based preventive screening and chronic disease monitoring in lung, liver, kidney and more
Gense offers an affordable and portable self-help medical imaging device for preventive screening and chronic disease monitoring at home and clinics. The device targets some of the costliest diseases’ early detection and chronic disease management for liver, lungs, kidney and more.Developed as a home-based medical imaging modality to assist telemedicine, the imaging scan is self-administrable by users without any substantive operative training, with app-based results generated by cloud-based machine learning algorithms.The award-winning startup is built by a team of 15 PhDs and researchers from Stanford, Cambridge, and Hong Kong. The team is also coordinating over 8 partnerships with professors on clinical trials and engineering. Gense has raised over USD 3mil from grants and investment to date, and developed capacity to mass manufacture with medical device certification. Their devices are deployed in public hospitals and used by the HK public sector to remotely monitor recovered COVID patients.The startup has also been approached by healthcare distributors from over 20 markets globally to set up local deployment pipeline, including private hospital network, clinic chains, health insurers, and multinational conglomerates.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 20, 2021 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Particle Accelerator Limited (ParticleX) | — | Seed |